The table below shows Altimmune, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$41.00K
$20.00K
$426.00K
-$68.00K
$4.41M
$8.19M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$66.43M
$82.23M
$65.80M
$70.54M
$74.54M
$49.77M
SG&A
ALT annual revenue (10-K history)
Altimmune, Inc. reported annual revenue of $41.00K for fiscal year 2025. That is up 105.0% from $20.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $3.24M (FY 2016) to $41.00K. Figures come from the company's audited annual reports as filed with the SEC.